Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001279569-18-001462
Filing Date
2018-07-12
Accepted
2018-07-12 08:30:18
Documents
7
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 20-F/A tv498031_20fa.htm 20-F/A 46577
2 EXHIBIT 4.1 tv498031_ex4-1.htm EX-4.1 360060
3 EXHIBIT 4.2 tv498031_ex4-2.htm EX-4.2 784483
4 EXHIBIT 4.3 tv498031_ex4-3.htm EX-4.3 286597
5 EXHIBIT 4.4 tv498031_ex4-4.htm EX-4.4 137047
6 EXHIBIT 4.5 tv498031_ex4-5.htm EX-4.5 398514
7 EXHIBIT 4.6 tv498031_ex4-6.htm EX-4.6 431361
  Complete submission text file 0001279569-18-001462.txt   2445864
Mailing Address 6TH FLOOR 1441 CREEKSIDE DRIVE VANCOUVER A1 V6J 4S7
Business Address 6TH FLOOR 1441 CREEKSIDE DRIVE VANCOUVER A1 V6J 4S7 1-604-677-6905
Correvio Pharma Corp. (Filer) CIK: 0001036141 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 20-F/A | Act: 34 | File No.: 000-29338 | Film No.: 18949683
SIC: 2834 Pharmaceutical Preparations